In Brief
Stress stimulates HSV reactivation from latent infection through unknown mechanisms. Cliffe et al. show that a neuronal stress pathway involving cJun N-terminal kinase (JNK) activation is crucial for HSV reactivation. JNK signaling induces histone phosphorylation on repressed viral promoters, therefore linking cell stress with initial stimulation of viral gene expression.
SUMMARY
Herpes simplex virus (HSV) reactivation from latent neuronal infection requires stimulation of lytic gene expression from promoters associated with repressive heterochromatin. Various neuronal stresses trigger reactivation, but how these stimuli activate silenced promoters remains unknown. We show that a neuronal pathway involving activation of c-Jun N-terminal kinase (JNK), common to many stress responses, is essential for initial HSV gene expression during reactivation. This JNK activation in neurons is mediated by dual leucine zipper kinase (DLK) and JNK-interacting protein 3 (JIP3), which direct JNK toward stress responses instead of other cellular functions. Surprisingly, JNK-mediated viral gene induction occurs independently of histone demethylases that remove repressive lysine modifications. Rather, JNK signaling results in a histone methyl/phospho switch on HSV lytic promoters, a mechanism permitting gene expression in the presence of repressive lysine methylation. JNK is present on viral promoters during reactivation, thereby linking a neuronal-specific stress pathway and HSV reactivation from latency.
INTRODUCTION
Herpes simplex virus (HSV) persists for the lifetime of the host in the form of a latent infection in peripheral neurons (Knipe and Cliffe, 2008; Roizman et al., 2013) . Periodically, HSV must reenter the lytic phase of replication in order to produce progeny virus for dissemination, a process known as reactivation. However, during latent infection, the viral lytic genes are extensively downregulated and their promoters assembled into repressive heterochromatin (Cliffe et al., 2009; Kwiatkowski et al., 2009; Wang et al., 2005) . Therefore, reactivation requires viral lytic gene expression to be induced from silenced promoters in the absence of viral proteins.
The earliest events in HSV reactivation are poorly understood, but recent work suggests that while similarities exist, there are several differences in the mechanisms of HSV gene expression during reactivation versus de novo lytic infection (Roizman et al., 2013) . During lytic replication, over 70 viral gene products are expressed in a cascade-dependent fashion. Recruitment of the cellular transcriptional machinery is dependent on both cellular and viral (HSV immediate-early activator, VP16) transcriptional transactivators to promote expression of the immediate-early (IE) mRNAs. Viral early (E) gene expression occurs following the synthesis of the IE proteins, and finally late (L) gene expression is dependent upon viral DNA replication (Roizman et al., 2013) . In contrast, during the early stages of reactivation the initial wave of lytic gene expression is not necessarily dependent upon VP16 expression (Kim et al., 2012) . In addition, E and L gene expression can occur in the absence of viral protein synthesis (Du et al., 2011; Kim et al., 2012; Thompson et al., 2009) , and L gene expression is not dependent on viral DNA replication (Kim et al., 2012) . This initial phase of viral gene expression appears to represent an event that is distinct from full reactivation (i.e., the production of infectious virus), and has been termed phase I or animation (Kim et al., 2012; Penkert and Kalejta, 2011) . During phase I, the observation that all three classes of viral genes are induced in the absence of viral protein synthesis suggests that host cell proteins initiate this process.
Although cellular proteins, including histone demethylases, have been found to be required for HSV reactivation (Hill et al., 2014; Liang et al., 2009 Liang et al., , 2012 Liang et al., , 2013 Messer et al., 2015) , as yet no direct link has been identified between a reactivation stimulus and the earliest induction of lytic gene expression. Reactivation of HSV can be trigged by different forms of neuronal stress including nerve growth factor (NGF) deprivation through inhibition of phosphoinositide 3-kinase (PI3K) signaling (Camarena et al., 2010; Du et al., 2011; Wilcox and Johnson, 1987) , axotomy (Carton and Kilbourne, 1952) , and heat shock (Miller et al., 2009; Sawtell and Thompson, 1992) . These stimuli also induce activation of the c-Jun N-terminal kinase (JNK) signaling pathway (Dorion and Landry, 2002; Estus et al., 1994; Kenney and Kocsis, 1998; Maroney et al., 1999; Tsui-Pierchala et al., 2000) . We therefore hypothesized that activation of JNK is a key event in HSV reactivation.
JNKs are members of the MAP kinase family that in mice are encoded by three different genes, Jnk1, Jnk2, and Jnk3. In the majority of cells types, JNKs are activated in response to cellular stress and cytokines. Neurons, however, have high levels of constitutive JNK activity that is required to regulate neuronal growth and homeostasis (Bjö rkblom et al., 2005; Chang et al., 2003) . The interaction of JNKs with different accessory proteins regulates whether they perform physiological or stress-inducible functions. For example, following a neuronal stress stimuli including NGF deprivation or axotomy, the mixed lineage kinase protein dual leucine kinase (DLK) along with the JNK scaffold protein, JNK-interacting protein-3 (JIP-3), redirect JNK to induce a stress response, characterized by phosphorylation of c-Jun (Miller et al., 2009; Ghosh et al., 2011; Welsbie et al., 2013) . Activation of JNK by DLK/JIP-3 can result in cell death, axon degeneration, or regeneration depending on the nature of the signal and maturation state of the neurons (Tedeschi and Bradke, 2013) .
To investigate the role of JNK in HSV reactivation, we developed a model of latency in primary mouse sympathetic neurons similar to that described previously using neurons isolated from rats (Camarena et al., 2010; Wilcox and Johnson, 1987) . Primary neuronal models are ideal for defining the cellular signaling pathways involved, as robust reactivation can be induced in pure populations of intact neurons. Using this model, we show that JNK activity is critical for reactivation of HSV. Specifically, we found that the neuronal stress pathway of JNK activation, which is dependent upon DLK and JIP-3, is required to trigger the earliest detectable induction of lytic gene expression during phase I of reactivation.
Because JNK-dependent phase I of reactivation requires the upregulation of gene expression from promoters associated with repressive histone modifications, we investigated whether histone demethylase activity was required. We found that neither LSD1 (H3K9-demethylase) nor UTX/JMJD3 (H3K27-demethylases) activities were necessary for phase I gene expression. Therefore, reversal of these repressive modifications was not required in this initial wave of gene expression. While the presence of H3K27me3 or H3K9me3 is typically associated with gene silencing, it is becoming increasingly appreciated that additional histone modifications, such as phosphorylation, can modulate this silencing function (Gehani et al., 2010; Karch et al., 2013; Rothbart and Strahl, 2014) . Indeed, we detected a JNK-dependent increase in phosphorylation on histone H3 that still maintained the K9me3 modification on nucleosome-associated viral lytic gene promoters. JNK itself was also enriched on lytic promoters during phase I. We therefore provide a direct link between activation of a neuronal stress response that would permit an increase in viral lytic gene expression from an epigenetically repressed state during phase I of HSV reactivation.
RESULTS

JNK Activity Is Required for HSV Reactivation
To investigate the role of the JNK in HSV reactivation, we utilized primary neurons isolated from the superior cervical ganglia (SCG) of postnatal mice to develop a system that would allow us to easily manipulate cellular signaling pathways in pure populations of neurons. Neurons were pretreated with type I and type II interferons and infected at a multiplicity of infection (MOI) of two plaque-forming units (PFUs) per cell with HSV-1 strain KOS expressing GFP-tagged version of the immediateearly activator protein (VP16) (Ottosen et al., 2006) in the presence of acyclovir ( Figure 1A ). After 6 days the acyclovir was removed. At this point there was an absence of GFP expression ( Figure 1B ) and increased expression of the latency-associated transcript (LAT) compared to the lytic ICP8 mRNA (see Figure S1A available online) . Reactivation was triggered by PI3K inhibition using LY294002, as previously described (Camarena et al., 2010; Kim et al., 2012; Kobayashi et al., 2012) (Figure 1B ). Reactivation was quantified based on the number of VP16-GFPexpressing neurons in the presence of WAY-150138 (van Zeijl et al., 2000) , which blocks packaging of the progeny genomes and therefore cell-to-cell virus spread ( Figures 1B and 1C) . WAY-150138 was effective in inhibiting the HSV-1 KOS replication in neurons ( Figure S1B ), confirming that we were quantifying reactivation and not viral spread.
PI3K inhibition resulted in the activation of JNK signaling, which is known to result in the upregulation and phosphorylation of the JNK target protein, c-Jun (Eilers et al., 1998) . JNK activation could be blocked by addition of the established JNK inhibitors SP600125 and AS601245 ( Figure 1D ). We found that inhibition of JNK signaling by either SP600125 or AS601245 completely blocked HSV reactivation triggered by PI3K inhibition as shown by the suppression of GFP positive neurons at 72 hr postreactivation (Figures 1E and 1F) . JNK inhibition also prevented the expression of the immediate-early protein, ICP4 (Figures S1C and S1D) . In addition to PI3K inhibition, reactivation has previously been found to be triggered by dexamethasone (Cook et al., 1991; Du et al., 2012) or AKT inhibition (Camarena et al., 2010) . We found that inhibition of JNK activity by SP600125 also prevented reactivation in the presence of dexamethasone ( Figure S1E ) or AKT VIII inhibitor ( Figure S1F ). Latent cultures of primary neurons isolated from the dorsal root ganglia (DRG) of mice were also established by infection with GFP-VP16 HSV in the presence of ACV ( Figure 1G ). Reactivation of HSV from DRG neurons could be triggered by PI3K inhibition, which we also found to be inhibited by addition of the JNK inhibitor, SP600125 ( Figure 1G ).
We next investigated the effect of JNK inhibition on reactivation of HSV from neurons that were infected in vivo. Latency was established in mice following corneal infection, and reactivation was triggered by explant/axotomy of the trigeminal ganglia (Liang et al., 2009 ). Axotomy of the trigeminal ganglia resulted in JNK activation, as determined by c-Jun phosphorylation, by 4 hr postexplant ( Figure S2 ). c-Jun phosphorylation could be reduced by addition of SP600125, although the level of inhibition was variable, likely due to incomplete penetrance of the JNK inhibitor into the explanted ganglia ( Figure S2 ). Following explant/axotomy-induced reactivation, addition of SP600125 reduced ICP27 mRNA expression at 6 hr postexplant ( Figure 2A ). Additionally, SP600125 also inhibited viral DNA replication ( Figure 2B ) and the production of infectious virus at 48 hr postexplant ( Figure 2C ). Thus, activation of JNK was found to be essential for reactivation from both sympathetic and sensory neurons, triggered by multiple stimuli in both in vitro and in vivo models of HSV latency.
Neuronal Apoptosis Is Dispensable for HSV Reactivation
Immature postnatal day 5 neurons are known to undergo apoptosis in response to NGF deprivation and PI3K inhibition (Kristiansen and Ham, 2014; Orike et al., 2001 ). This apoptosis is dependent upon activation of JNK signaling (Besirli and Johnson, 2003; Eilers et al., 1998) . Neurons will also undergo apoptosis in response to dexamethasone (Du et al., 2012) . Therefore, HSV reactivation could be either directly triggered by JNK signaling or a consequence of neuronal cell death. However, previous studies have demonstrated that immature neurons develop resistance to apoptosis as they mature both in vitro and in vivo (Kole et al., 2013) . Consistent with this observation, neither PI3K inhibition nor dexamethasone resulted in neuronal cell death in these postnatal day 18 (the same age of neurons at the time of reactivation) mature neurons ( Figure 3A ). To definitively rule out a potential role for apoptosis in this reactivation assay, we utilized neurons that are deficient in the proapoptotic protein, Bax. Since SCG neurons do not expression Bak, deletion of Bax is sufficient to completely inhibit apoptosis in these neurons (Kristiansen and Ham, 2014) . HSV reactivation was found to be equivalent in Bax knockout and wild-type neurons ( Figure 3B ). These results indicate that the neuronal stress pathway of JNK signaling, and not cell death, was critical for triggering HSV reactivation.
JNK Activation by DLK/JIP-3 Is Required for HSV Phase I of Reactivation
We next examined whether activation of the JNK cell stress pathway was directly required to induce the transcription of the initial wave of viral lytic mRNAs during phase I. In our system, the representative lytic mRNAs ICP27 and ICP8 were induced between 15 and 20 hr postreactivation ( Figures 4A and S3A) . Strikingly, inhibition of JNK by SP600125 blocked both ICP27 and ICP8 mRNAs induction at 18 hr postreactivation (Figures (E) Reactivation of HSV from primary neurons isolated from the SCG triggered by LY294002 is blocked by SP600125 as determined by the numbers of VP16-GFP expressing cells 72 hr postreactivation (mean ± SEM, n = 8).
(F) Reactivation from primary neurons isolated from the SCG triggered by LY294002 is blocked by AS601245 as determined by the numbers of VP16-GFP-expressing cells 72 hr postreactivation (mean ± SEM, n = 9). (G) Reactivation of HSV from primary neurons isolated from the dorsal root ganglia (DRG) triggered by LY294002 is blocked by SP600125 as determined by the numbers of VP16-GFP expressing cells 72 hr postreactivation (mean ± SEM, > = 9). SP600125 and AS601245 were both added at the time of reactivation. All reactivation experiment were carried out in the presence of WAY-150138 (10 mg/ml) to block cell-to-cell spread. See also Figure S1 .
4B and S3B). In contrast, inhibition of JNK had no effect on ICP27 gene expression following de novo lytic infection of neurons ( Figure S3C ). Therefore, JNK activation is required for phase I gene expression during reactivation, but not IE gene expression during lytic replication in neurons.
In neurons, stress signaling including both local and axonspecific NGF deprivation and axotomy activates JNK via DLK and JIP-3 (Miller et al., 2009; Ghosh et al., 2011; Welsbie et al., 2013) . To determine whether DLK and JIP-3 were required for HSV reactivation, we depleted either DLK or JIP-3 protein using lentivirus-mediated delivery of shRNAs. We found that depletion of either protein blocked the induction of ICP27 gene expression at 18 hr postreactivation ( Figures  4C-4E) . Hence, activation of the neuronal-specific pathway of JNK by DLK/JIP-3 was required for the induction of viral lytic gene expression during phase I of reactivation. Depletion of DLK or JIP-3 did not reduce ICP27 mRNA levels following de novo infection ( Figures S3D-S3F ), indicating that distinct mechanisms regulate lytic gene expression during phase I of reactivation versus lytic replication.
Phase I of Reactivation Is Independent of Histone Demethylase Activity
During latent infection, HSV promoters are associated with histone H3 trimethylated at lysine 27 (H3K27me3) and histone H3 di-and trimethylated at lysine 9 (H3K9me2/3) (Cliffe et al., 2009; Kwiatkowski et al., 2009; Wang et al., 2005) . Therefore, we investigated whether removal of these repressive histone modifications was required for the induction of lytic gene expression during phase I. We first confirmed that the representative viral lytic gene promoters (ICP27 and ICP8) were assembled into heterochromatin in the primary neuronal model by chromatin immunoprecipitation (ChIP) assays. Both the ICP27 and ICP8 promoters were found to be associated with H3K27me3 ( Figures  5A and 5B) and H3K9me3 ( Figures 6A and 6B ) in latently infected primary neurons.
GSK-J4 is a compound that blocks both of the histone lysine 27 demethylases, UTX and JMJD3 (Kruidenier et al., 2012) , and has been shown to inhibit HSV reactivation (Messer et al., 2015) . Addition of GSK-J4 blocked HSV reactivation as determined by the detection of GFP-positive neurons ( Figure 5C ). However, GSK-J4 did not inhibit the induction of ICP27 or ICP8 mRNA during phase I (Figures 5D and 5E ). In contrast, we found GSK-J4 reduced ICP27 expression by approximately 70% during lytic infection in neurons ( Figure 5F ), consistent with the requirement for UTX for maximal IE gene expression during lytic infection (Oh et al., 2013) . These results highlight the observation that while H3K27me3 demethylase activity is required for gene expression during lytic replication, it does not appear to be required for phase I of reactivation.
During HSV reactivation, the histone demethylases LSD1 and JMJD2 are required for the removal of H3K9 methylation (Liang et al., 2009 (Liang et al., , 2013 . Inhibition of LSD1 activity using monoamine oxidase inhibitors (MAOIs) such as tranylcypromine (TCP) (Lee et al., 2006; Metzger et al., 2005) blocks reactivation in the mouse explant model system (Liang et al., 2009 ) and prevents recurrence in vivo (Hill et al., 2014) . As shown in Figures 6A and 6B , histone H3K9me3 was associated with lytic gene promoters in latently infected neurons. In a manner comparable to treatment with GSK-J4, addition of TCP inhibited HSV reactivation ( Figure 6C ) but did not prevent ICP27 or ICP8 mRNA induction during phase I (Figures 6D and  6E) . TCP reduced ICP27 expression by over 70% during lytic infection of neurons ( Figure 6F ), once again highlighting the difference between lytic replication and phase I of reactivation. Taken together, these results show that the first phase of gene expression during HSV reactivation is dependent on the JNK cell stress pathway but independent of H3K27 and H3K9 histone demethylase activity. 
JNK Signaling Triggers a Methyl/Phospho Switch on Lytic Promoters
We next examined how JNK signaling could permit increased viral gene expression during phase I without the removal of the repressive heterochromatin modifications. One mechanism by which cellular gene expression can be initiated even in the presence of repressive lysine methylation is through histone phosphorylation on a neighboring serine (i.e., H3S10 and H3S28). This is known as a histone methyl/phospho switch and has been demonstrated to occur following the activation of kinase signaling pathways (Fischle et al., 2003 (Fischle et al., , 2005 Gehani et al., 2010; Hirota et al., 2005) . To investigate the potential of such a mechanism in HSV reactivation, we first tested the specificities of several commercially antibodies raised against H3K9me3, H3K27me3, and the neighboring phosphorylation marks using a histone peptide microarray platform (Fuchs et al., 2011; Rothbart et al., 2012) (Figures S4A-S4F ). Generating these antibody specificity profiles was especially important since binding of an antibody to a single histone modification can be occluded by a combination of modifications (Fuchs et al., 2011) . We identified an antibody that was specific for the dually modified histone H3K9me3/pS10 but not for either of the single S10 or K9 modifications ( Figure S4C ). Using this antibody, we detected a robust increase in the enrichment of H3K9me3/pS10 on the ICP27 and ICP8 viral lytic gene promoters, during phase I of reactivation ( Figures 7A and 7B ). In contrast, we did not detect an increase in H3K9me3/pS10 enrichment at the latency-associated transcript (LAT) 5 0 exon, which is depleted of H3K9me3 during latency (Cliffe et al., 2009) (Figure 7C) . Importantly, the increase in H3K9me3/pS10 seen on viral lytic promoters was blocked when JNK activity was inhibited ( Figures 7A and 7B ), indicating that JNK signaling resulted in phosphorylation of histone H3 at S10 while still maintaining H3K9 methylation.
The kinases that have been demonstrated to phosphorylate histone H3S10 in the context of lysine methylation include mitogen-and stress-activated kinases (MSKs) (Gehani et al., 2010; Sabbattini et al., 2014) and Aurora B kinase (Fischle et al., 2005; Hirota et al., 2005; Sabbattini et al., 2014) . However, we found no role for these kinases in reactivation ( Figures 7D and  7E) . Recently, JNK itself was shown to have the ability to of phosphorylate H3S10 in vitro (Tiwari et al., 2012) . To examine the possibility that JNK directly phosphorylates histone H3 during HSV reactivation, we examined JNK occupancy on lytic promoters during reactivation. Our results show that JNK was enriched on viral lytic promoters, but not on the control LAT 5 0 exon, during reactivation ( Figure 7F ). Taken together, these data suggest that JNK occupancy of viral promoters mediates the histone methyl/phospho switch that would permit viral gene expression from repressed heterochromatin during HSV reactivation.
DISCUSSION
It has been long hypothesized that neuronal cell stress results in reactivation of HSV, yet the stress-signaling pathways mediating reactivation have remained undiscovered. Using a primary neuronal model of HSV latency and reactivation, we found that the DLK/JIP-3 JNK stress pathway is a key mediator of HSV reactivation in neurons and triggers the earliest detectable upregulation in lytic gene expression. Importantly, we found that activation of the JNK pathway resulted in phosphorylation of histone H3 associated with HSV lytic promoters, which could allow viral lytic gene expression to occur without removal of repressive lysine modifications.
The pathway of JNK activation by DLK and JIP-3 has been described for various types of neuronal insults that occur on either the whole neuron and localized only to the axon, including local or global NGF-deprivation and axotomy (Miller et al., 2009; Ghosh et al., 2011; Welsbie et al., 2013) . We hypothesize that activation of the DLK/JIP-3 JNK pathway is a major trigger of HSV reactivation in response to various stimuli in vivo. Recent work has suggested that latency may be significantly dynamic with low levels of lytic gene expression in individual neurons and/or infrequent abortive reactivation events (Ma et al., 2014; Margolis et al., 2007) . Increased viral gene expression in this context was associated with changes in cellular gene expression, including upregulation of Bim mRNA (Ma et al., 2014) , which is a key target of the DLK/JIP-3 JNK pathway (Harris and Johnson, 2001 ). We propose that this low level of lytic gene expression could result from limited activation of the neuronal-specific JNK cell stress pathway, perhaps following small insults to neurons. Viral reactivation could be completed when these signaling pathways reach full threshold. As DLK and JIP-3 are expressed almost exclusively in neurons (Hirai et al., 2005; Kelkar et al., 2000) , targeting them would be an effective mechanism to prevent HSV reactivation in response to multiple triggers.
We have further defined phase I of reactivation as being dependent upon JNK signaling but independent of histone demethylase activity. Previous work has also found that phase I occurs independently of viral protein synthesis (Du et al., 2011; Kim et al., 2012) and expression of the lytic transactivator VP16 (Kim et al., 2012) . Although phase I occurred even in the absence of histone demethylase activity, we found that lytic gene expression following de novo infection in neurons was dependent upon histone demethylase activity, supporting previous observations in nonneuronal cells (Liang et al., 2009 (Liang et al., , 2012 (Liang et al., , 2013 Oh et al., 2013) . Therefore, the mechanisms of lytic gene expression during phase I and de novo infection are distinct. Perhaps this is not surprising, given that gene expression needs to be induced from promoters with different chromatin structures in reactivation versus de novo infection (Deshmane and Fraser, 1989; Kent et al., 2004; Lentine and Bachenheimer, 1990; Wang et al., 2005) . Additionally, in contrast to de novo infection, gene expression during reactivation needs to be induced in the absence of viral transcriptional activators that can promote the recruitment of coactivator complexes containing chromatin remodeling proteins and histone demethylases.
Our results also support previous observations that full reactivation requires the activity of histone demethylases, most likely once a threshold for lytic gene expression is reached. Therefore, targeting histone demethylase activity along with the JNK pathway would be an effective, multistep approach to prevent HSV reactivation. Previous work identifying a role for the histone demethylases LSD1 and JMJD2s in explant/axotomy-induced reactivation found that they were required for lytic gene expression at 6 hr postreactivation (Liang et al., 2009 (Liang et al., , 2013 . Explant is known to induce rapid changes in cellular and viral lytic gene expression (Rishal and Fainzilber, 2014; Sawtell and Thompson, 2004) ; therefore it is possible that histone phosphorylation and demethylation are more tightly coupled following explantinduced reactivation compared to reactivation in intact neurons. The viral lytic transactivator VP16 is required for full reactivation following thermal stress in vivo ) and PI3K inhibition in primary neurons (Kim et al., 2012) , but not following explant-induced reactivation (Sears et al., 1991; Steiner et al., 1990) . Therefore an alternative hypothesis is that there are differences in the pathways to reactivation in axotomized ganglia versus intact neurons. Irrespective, in this study JNK activity was found to be required for the earliest stages of reactivation in both explanted and intact neurons.
Our results identify a direct link between activation of the DLK/ JIP-3 JNK neuronal stress pathway and histone methyl/phospho switch that could allow gene expression to occur even without the removal of repressive lysine modifications ( Figure 4G) . A histone methyl/phospho switch is thought to result in the eviction of histone readers that bind the methylated histones but are unable to do so when the neighboring serine residue is phosphorylated (Fischle et al., 2003 (Fischle et al., , 2005 Gehani et al., 2010; Hirota et al., 2005; Sabbattini et al., 2014) . Specifically, we detected enrichment in the H3K9me3/pS10 modification during the phase I phase of reactivation that was dependent upon JNK activity. A histone methyl/phospho switch occurring at S10 has been found to result in the loss of HP1 binding to H3K9me3 during mitosis and loss of Polycomb group protein EZH1 binding to developmentally regulated genes in embryonic stem cells (Fischle et al., 2005; Hirota et al., 2005; Sabbattini et al., 2014) . Histone phosphorylation can result in either transcriptional silencing or activation, depending upon the context (Sawicka and Seiser, 2014) . Our results suggest that a JNK-mediated H3K9me3/ pS10 switch in neurons results in HSV transcriptional activation during phase I of reactivation.
Thus far, the kinases found to be responsible for an H3K9me3/ pS10 switch are the MSKs and Aurora B kinase (Fischle et al., 2005; Hirota et al., 2005; Sabbattini et al., 2014) . As we found no role for these kinases in HSV reactivation, we conclude that they likely do not play a major role in mediating the methyl/phospho switch during phase I. Furthermore, JNK mediates histone S10 phosphorylation during neuronal development, which is associated with transcriptional activation (Tiwari et al., 2012) . However, in this context phosphorylation was not found to occur in the presence of H3K9 methylation. Our results now link JNK activity with an H3K9me3/ pS10 switch.
In the context of HSV reactivation, maintaining the repressive histone-lysine modifications through the use of a methyl/phospho switch may allow the viral genome to become easily rerepressed if the threshold for full reactivation is not reached. Previous work from Kim et al. (2012) has suggested only a subpopulation of neurons that undergo phase I progress to full reactivation, indicating that this step is indeed reversible. Importantly, by highjacking a neuronal signaling pathway, HSV has evolved a mechanism that allows the earliest gene expression to occur from repressed chromatin in the absence of viral-encoded activators. While our results show that this histone methyl/phospho switch allows for HSV reactivation, a similar mechanism may also permit cellular gene expression from repressed chromatin in other situations of neuronal stress.
EXPERIMENTAL PROCEDURES Primary Neuronal Cultures
Sympathetic neurons were dissected from the SCG of postnatal days 1-3 (P1-P3) CD1 mice (Charles River Laboratories) or Bax knockout/WT litter mate controls (Knudson et al., 1995) as previously described (Deshmukh et al., 2002) . Sensory neurons were isolated from the DRG of P0-P1 CD-1 mice. All animal handling and protocols were approved by the Animal Care and Use Committee of the University of North Carolina (UNC). Briefly, ganglia were placed in Leibovitz's L-15 before incubation in collagenase (1 mg/ml) followed by trypsin (2.5 mg/ml) for 20 min each at 37 C and plated onto rat tail collagen. Sympathetic neurons were maintained in AM50 media (MEM with the addition of 50 ng/ml 2.5S NGF, 10% fetal calf serum, 2 mM glutamine, 100 mg/ml penicillin, 100 mg/ml streptomycin, 20 mM fluorodeoxyuridine, and 20 mM uridine). Aphidicolin (3.3 mg/ml) was also added to the media for 3 days postplating to remove any proliferating cells. Sensory neurons were maintained in DRG media (NeuroCult Neurobasal media (Stem Cell Technologies), SM1 (Stem Cell Technologies), 4.5 g/L glucose, 50 ng/ml 2.5S NGF, 10 ng/ml glial derived neurotropic factor, 2 mM glutamine, 100 mg/ml penicillin, 100 mg/ml streptomycin, 20 mM fluorodeoxyuridine, and 20 mM uridine).
Aphidicolin (3.3 mg/ml) was also added to the media for 2 days postplating, followed by cytosine arabinoside (3 mM) for 2 days to remove proliferating cells.
Establishment and Reactivation of Latent HSV-1 Infection in Primary Neurons
To establish HSV latently infected cultures in neurons isolated from SCGs, P9 neurons were pretreated with 100 u/ml mouse IFN-alpha (Millipore) and 250 u/ml mouse IFN-gamma (Millipore) in AM50 without fluorodeoxyuridine and uridine (AM50-FUDR). After 24 hr, the cultures were infected with HSV-DG1 (KOS recombinant HSV expressing a VP16-GFP fusion protein) (Ottosen et al., 2006) . Neurons were infected at an MOI of 2 PFU/cell (assuming 10 4 neurons/well/24-well plate or at 10 4 PFU/ml) in PBS containing 1% FBS, 4.5 g/L glucose, and 100 mM acyclovir (ACV) for 2 hr. Postinfection, the media was changed to AM50-FUDR containing 100 mM (ACV) for 6 days, and then AM50-FUDR. For the establishment of latently infected cultures of neurons isolated from DRGs, P5 neurons were infected at an MOI of 1 PFU/cell and maintained in DRG media without FUDR containing 100 mM (ACV) for 4 days to allow for the establishment of latent infection, and then DRG media without FUDR. WAY-150138 (10 mg/ml) was added to limit cell-to-cell spread. Reactivation was quantified by counting the numbers of GFP-positive neurons. Analyses of the distributions were carried out by KS normality tests, and statistical comparisons were made using two-tailed paired Student's t test (Prism V5.0c).
Mouse Infections and Explant-Induced Ex Vivo Reactivation
Establishment and reactivation of HSV in murine trigeminal ganglia were carried out as described previously (Liang et al., 2012) . Mice were infected by corneal scarification with 2 3 10 5 PFU/eye HSV-1 strain F. At 30-45 days postinfection, latently infected trigeminal ganglia were bisected, and each half was explanted into media-containing vehicle (DMSO) or SP600125 (10 mM) for 48 hr. The resulting viral yields were determined by titers of the ganglia homogenates on Vero cell monolayers. DNA was prepared from aliquots of the paired ganglia using ZR Genomic DNA-Tissue Miniprep Kit (Zymo), and HSV DNA levels were determined by qPCR using FastStart Universal SYBR Green Master Mix (Roche) in an Eppendorf Realplex 4 . HSV (UL30) and control GAPDH primer sets are as described (Hill et al., 2014) . All animal care and handling were done in accordance with the NIH Animal Care and Use Guidelines and as approved by the NIAID Animal Care and Use Committee. Statistical comparisons were made using two-tailed Wilcoxon signed-rank test (Prism V5.0c). To determine positive enrichment, the amount of viral DNA immunoprecipitated with a JNK-specific antibody was normalized to the amount precipitated with a non-specific control antibody. Data represent the mean ± SEM, n = 5. (G) Model depicting histone modifications on HSV lytic promoters during latency and following neuronal cell stress stimuli triggering DLK/JIP-3-mediated activation of JNK and the contribution of histone demethylase activity. We hypothesize that a histone methyl/phospho switch also occurs at H3K27me3/pS28. Euchromatin-associated marks enriched on lytic promoters during reactivation (e.g., acH3K9/14; Neumann et al., 2007) are also represented in phase II, although whether histone acetylation is required for phase I or phase II has not been fully established in a neuronal stress model. See also Figure S4 . 
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